ArticleJournal of enzyme inhibition and medicinal chemistry2025
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents.
Jason H Gill et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.